Member Directory

We help pharma, biotech and pharma service companies to enhance collaboration and teamwork, by improving project management and relationship management in partnerships and alliances. We provide training, particularly for new project managers, consulting for small and medium-sized companies and coaching for project and outsourcing leaders. We deliver the One Nucleus Project Management training course and lead the One Nucleus Alliance and Project Management Special Interest Group. We are a small, agile operation, can work flexibly according to companies' exact needs, and can help with any relevant issue, large or small.
Watch our Member Showcase Video

PASM offers clinical trial support services, with special expertise in helping SMEs. Projects undertaken span planning a clinical trials program to meet a regulatory strategy, through to designing and implementing outsourcing strategies to fit the company's needs.

With a portfolio of more than 3,000 products covering the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity, Promega is a global leader in providing innovative solutions and technical support to life scientists in academic, industrial and government settings.. Promega products are used by life scientists who are asking fundamental questions about biological processes as well as by scientists who are applying scientific knowledge to diagnose and treat diseases, discover new therapeutics, and use genetics and DNA testing for human identification.. . Promega holds significant intellectual property rights and licenses in several key areas that form a foundation for its diverse portfolio including:. •

Protogenia Consulting Ltd offers non-clinical and early clinical development consultancy services, with more than 15 years' outsourcing and project management experience gained through virtual and mid-sized pharmaceutical companies. The services offered include: strategic planning to enable early clinical development and product registration; non-clinical and clinical project management; regulatory submission writing/review/sign-off (e.g. CTA/IND, MAA/NDA, IMPD and IB); and CRO selection and study management – clinical (up to Phase 2) and non-clinical (toxicology, safety pharmacology, ADME, bioanalysis). In addition, we have a broad network of contacts, for expert advice on IP, CMC, analytical services, regulatory affairs and quality assurance.